Camp4 Therapeutics (CAMP) Operating Expenses (2023 - 2026)

Camp4 Therapeutics' Operating Expenses history runs 4 years deep, the most recent figure standing at $14.4 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 2.92% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $56.5 million (up 2.99% YoY), while the FY2025 annual figure was $56.1 million, up 4.3% from the prior year.
• Operating Expenses came in at $14.4 million for Q1 2026 at Camp4 Therapeutics, up from $13.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $14.7 million in Q4 2024 to a low of $12.7 million in Q2 2024.
• A 4-year average of $13.7 million and a median of $13.5 million in 2024 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 14.71% in 2025 and fell as far as 10.64% in 2025.
• Camp4 Therapeutics' Operating Expenses stood at $13.5 million in 2023, then advanced by 8.98% to $14.7 million in 2024, then retreated by 10.64% to $13.1 million in 2025, then climbed by 9.46% to $14.4 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $14.4 million, $13.1 million, and $14.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison